ACC Market Growth Dynamics: Orphan Drugs, Genomics & Clinical Trials
Drivers include orphan drug benefits, genetic profiling enabling precision therapy, and a robust pipeline of trials—yet slowed by rarity and heterogeneity of ACC.
Source: https://www.marketresearchfutu....re.com/reports/adren